These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20027813)

  • 1. Stop a killer before it's too late.
    Walsh PC
    US News World Rep; 2009 Dec; 146(11):18. PubMed ID: 20027813
    [No Abstract]   [Full Text] [Related]  

  • 2. To screen or not to screen? Prostate cancer screening: why it's not for every man.
    Lefevre M
    Medscape J Med; 2008; 10(8):181. PubMed ID: 18924633
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing prostate cancer. Finasteride shrinks enlarged prostates and may prevent some cases of prostate cancer. But it's no panacea.
    Beer TM
    Health News; 2003 Aug; 9(8):1-2. PubMed ID: 12971313
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the prostate: overview of the most common malignancy in men.
    Carson CC
    N C Med J; 2006; 67(2):122-7. PubMed ID: 16752715
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
    Walsh PC
    J Urol; 2009 Mar; 181(3):1499; author reply 1499-500. PubMed ID: 19157429
    [No Abstract]   [Full Text] [Related]  

  • 6. Clarification of prostate cancer screening recommendations.
    Merenstein D
    Am Fam Physician; 2004 Sep; 70(5):817; discussion 817, 821. PubMed ID: 15368718
    [No Abstract]   [Full Text] [Related]  

  • 7. It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer.
    Thompson IM; Ankerst DP; Etzioni R; Wang T
    J Urol; 2008 Oct; 180(4):1219-22. PubMed ID: 18707707
    [No Abstract]   [Full Text] [Related]  

  • 8. [PSA level--is 4.0 ng/ml as upper limit too high].
    Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
    [No Abstract]   [Full Text] [Related]  

  • 9. It's sometimes safe to delay prostate surgery. "Watchful waiting" plus active surveillance still leaves a window of opportunity if surgery is necessary.
    Health News; 2006 Jun; 12(6):13-4. PubMed ID: 16832884
    [No Abstract]   [Full Text] [Related]  

  • 10. Current role of prostate-specific antigen kinetics in managing patients with prostate cancer.
    Teahan SJ; Klotz LH
    BJU Int; 2006 Mar; 97(3):451-5. PubMed ID: 16469006
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies.
    Parekh DJ; Ankerst DP; Thompson IM
    J Natl Cancer Inst; 2007 Apr; 99(7):496-7. PubMed ID: 17405989
    [No Abstract]   [Full Text] [Related]  

  • 12. What is the difference between screening and diagnostic tests?
    Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):8. PubMed ID: 12154802
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer screening: why it's not for every man.
    Lakhan SE
    Medscape J Med; 2008; 10(8):182; author reply 182. PubMed ID: 18924634
    [No Abstract]   [Full Text] [Related]  

  • 14. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate specific antigen screening.
    Block KI
    Integr Cancer Ther; 2009 Jun; 8(2):111-2. PubMed ID: 19679618
    [No Abstract]   [Full Text] [Related]  

  • 16. On call. I've had my PSA tested every year since 1992 and I'm happy to say it's always been normal. But now my doctor doesn't want to do the test anymore because I'm 78 years old. Should I go to another doctor for my test?
    Simon HB
    Harv Mens Health Watch; 2000 Dec; 5(5):8. PubMed ID: 11114879
    [No Abstract]   [Full Text] [Related]  

  • 17. Stats & Facts. Prostate-specific antigen screening.
    Manag Care Interface; 2001 Jul; 14(7):40-1. PubMed ID: 11481814
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversy in clinical cancer screening--prostate-specific antigen.
    McKay DA
    West J Med; 1994 Jul; 161(1):58-9. PubMed ID: 7524244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.